Come up with a name for your new list and we'll add to it:
Zhejiang Beta Pharma raised a round of funding on June 11, 2010. Investors include
Lilly Asia Ventures.
Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug I…